Nuzenio

Oncology Drug

Oncology Drug news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 22 publisher sources 100/100 entity strength

Latest news

Zai Lab: Zoci Advances From IND To Global Phase 3 In Under Two Years As U.S. Submission Targets 2027 - Pulse 2.0Pulse 2.0 · Sun, 09 Aug 2026 11:55:53 GMTPatients in Illinois starting to receive experimental pancreatic cancer drug: ‘Game changer’ - Chicago TribuneChicago Tribune · Sun, 09 Aug 2026 11:00:17 GMTWatching cancer cells live could open new frontiers in drug discovery: Experts - The TribuneThe Tribune · Sun, 09 Aug 2026 08:41:38 GMTScientists identify which cancer patients would respond well to glaucoma drugs - The Institute of Cancer Research (ICR)The Institute of Cancer Research (ICR) · Sat, 08 Aug 2026 07:45:26 GMTReplimune’s First Commercial Drug Arrives—With A 2027 Cash Cliff And 2030 Finish Line - TradingViewTradingView · Sat, 08 Aug 2026 00:31:00 GMTBlossomHill Therapeutics, Clinical-Stage Oncology Drug Developer, Files for Nasdaq Global Select Market IPO - TradingViewTradingView · Fri, 07 Aug 2026 20:09:00 GMTExtending Drug Exposure Without Systemic Toxicity in NMIBC Treatment - CancerNetworkCancerNetwork · Fri, 07 Aug 2026 19:09:52 GMTFrom competitors to collaborators: How oncology brands are working together to market combination therapies - mmm-online.commmm-online.com · Fri, 07 Aug 2026 17:03:29 GMT

Timeline

Sun, 09 Aug 2026 11:55:53 GMTZai Lab: Zoci Advances From IND To Global Phase 3 In Under Two Years As U.S. Submission Targets 2027 - Pulse 2.0
Sun, 09 Aug 2026 11:00:17 GMTPatients in Illinois starting to receive experimental pancreatic cancer drug: ‘Game changer’ - Chicago Tribune
Sun, 09 Aug 2026 08:41:38 GMTWatching cancer cells live could open new frontiers in drug discovery: Experts - The Tribune
Sat, 08 Aug 2026 07:45:26 GMTScientists identify which cancer patients would respond well to glaucoma drugs - The Institute of Cancer Research (ICR)
Sat, 08 Aug 2026 00:31:00 GMTReplimune’s First Commercial Drug Arrives—With A 2027 Cash Cliff And 2030 Finish Line - TradingView
Fri, 07 Aug 2026 20:09:00 GMTBlossomHill Therapeutics, Clinical-Stage Oncology Drug Developer, Files for Nasdaq Global Select Market IPO - TradingView

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.PoliticsPolitics stories explain decisions, institutions, parties, leaders, laws, budgets, elections, courts, and public accountability.

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Oncology Drug.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

22 distinct publisher/source names are currently connected to this entity page.